4//SEC Filing
TANEN DAVID M 4
Accession 0001209191-20-055044
CIK 0001741830other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 3:54 PM ET
Size
21.4 KB
Accession
0001209191-20-055044
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
TANEN DAVID M
Director
Transactions
- Conversion
Common Stock
2020-10-14+68,831→ 434,111 total(indirect: See footnote) - Conversion
Series Seed Preferred Stock
2020-10-14−219,482→ 0 total→ Common Stock (231,553 underlying) - Conversion
Common Stock
2020-10-14+231,553→ 363,428 total - Conversion
Series A Preferred Stock
2020-10-14−65,243→ 0 total(indirect: See footnote)→ Common Stock (68,831 underlying) - Conversion
Common Stock
2020-10-14+233,405→ 365,280 total(indirect: See footnote) - Conversion
Series Seed Preferred Stock
2020-10-14−221,237→ 0 total(indirect: See footnote)→ Common Stock (233,405 underlying) - Conversion
Convertible Promissory Note
2020-10-14→ 0 total(indirect: See footnote)Exercise: $16.15Exp: 2022-02-20→ Common Stock (37,119 underlying) - Conversion
Common Stock
2020-10-14$16.15/sh+37,119$599,472→ 471,230 total(indirect: See footnote)
Holdings
- 26,375(indirect: By Son)
Common Stock
- 26,375(indirect: By Daughter)
Common Stock
- 26,375(indirect: By Son)
Common Stock
Footnotes (3)
- [F1]Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]By the David Tanen Revocable Grantor Trust.
- [F3]The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
Kronos Bio, Inc.
CIK 0001741830
Entity typeother
Related Parties
1- filerCIK 0001170542
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 3:54 PM ET
- Size
- 21.4 KB